IMGN insider trading

IMMUNOGEN INC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
339
Last 90 days
0
Buys / sells
1% / 21%
Market cap

IMGN insider activity at a glance

FilingIQ has scored 339 insider transactions for IMGN since Apr 2, 2015. The most recent filing in our index is dated Feb 12, 2024.

Across the full history, 3 open-market purchases and 70 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on IMGN insider trades is 69.2/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest IMGN Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

13F funds holding IMGN

Frequently asked

How many insider trades does FilingIQ track for IMGN?
FilingIQ tracks 339 Form 4 insider transactions for IMGN (IMMUNOGEN INC), covering filings from Apr 2, 2015 onwards. 0 of those were filed in the last 90 days.
Are IMGN insiders net buyers or net sellers?
Across the full Form 4 history for IMGN, 3 transactions (1%) were open-market purchases and 70 (21%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does IMGN insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

Methodology & sources

Every IMGN insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.